Singapore is Southeast Asia's most mature supplement market and a gateway to the broader ASEAN region. Regulatory oversight sits with the Health Sciences Authority (HSA), and the framework is predictable and relatively efficient compared to other Asian markets — making Singapore a strong first Asian market for international brands.
Singapore classifies products as Health Products, Chinese Proprietary Medicines, or conventional food. Most Western-style supplements fall under the Health Products Act as 'Chinese proprietary medicines' or — more commonly for international brands — are notified as Western health products. The classification determines which regulatory pathway applies.
Products making therapeutic claims must be registered with HSA. Products sold purely as nutritional supplements with no therapeutic claims can often be sold without HSA registration if they don't trigger classification as a health product. In practice, any product sold in pharmacies or making any health-related claim should seek HSA notification. The process takes 2–3 months for standard products.
English labels are accepted (Singapore is English-speaking). Required elements: product name, net quantity, ingredient list, nutritional information per serving, country of origin, importer name and Singapore address, and expiry date. HSA-registered products must carry their HSA registration number.
Singapore strictly enforces its list of controlled substances. Products containing any Misuse of Drugs Act scheduled substances are illegal regardless of concentration. Some herbal ingredients (kava, ephedra) are prohibited. HSA maintains an updated list — check every ingredient before formulating for the Singapore market.
Ready to go deeper?
Get your Singapore market entry blueprint including HSA compliance pathway, retailer contacts, and ASEAN expansion roadmap.